Predictive Oncology Inc POAI

Healthcare Medical Devices

Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.

NDAQ:POAI - Post by User

Predictive Oncology Inc

<< Previous

Bullboard Posts

Post by whytestockson Aug 27, 2024 4:03pm

23 Views

Post# 36198290

InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI)

Just In: $POAI InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Reports on Study Confirming Long-Term Stability, Viability of Proprietary Tumor Specimen BiobankPredictive Oncology (NASDAQ: POAI) , a leader in artificial-intelligence (“AI”)-driven drug discovery and biologics, is reporting on a study that demonstrates the long-term stability and viability of the more than 150,000 cryopreserved patient tumor samples available within its prop...POAI - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Reports on Study Confirming Long-Term Stability, Viability of Proprietary Tumor Specimen Biobank

<< Previous

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario